instruction stringlengths 225 2.35k | input stringlengths 89 1.5k | response stringclasses 698 values |
|---|---|---|
<Instruct>: Given the context 'The reasons may be lying in the specific characteristics of this patient group itself.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patient]
<Options>: A: circe
B: mouse (aka mus musculus)
C: homo sapiens (human) (aka homo sapiens)
D: other (aka unidentified)
E: suborder
F: None of the above. | [C] |
<Instruct>: Given the context 'The study included patients suffering from chronic symptoms; with an average of 7,44 ± 6,82 years of pain in the alexithymic and 3,31 ± 2,79 years in the nonalexithymic groups.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: this
B: theraps
C: homo sapiens (human) (aka homo sapiens)
D: goes
E: kingdom
F: None of the above. | [C] |
<Instruct>: Given the context 'It is not known whether it should be addressed in the treatment of pain patients, but a high level of alexithymia may effect the nature of assessment.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: species
B: goes
C: homo sapiens (human) (aka homo sapiens)
D: aides
E: probles
F: None of the above. | [C] |
<Instruct>: Given the context 'SuperCAT: a supertree database for combined and integrative multilocus sequence typing analysis of the Bacillus cereus group of bacteria (including B. cereus, B. anthracis and B. thuringiensis)
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. cereus; b. anthracis; b. thuringiensis]
<Options>: A: bacillus cereus biovar anthracis
B: bacillus subtilis group
C: bacillus cereus group
D: anthracus
E: cereus (aka cereus <sea anemones>)
F: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
G: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
H: bacillus/clostridium group (aka bacillota)
I: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
J: bacillus thuringiensis serovar brasilensis (bacillus thuringiensis serovar brasiliensis) (aka bacillus thuringiensis serovar brasilensis)
K: bacillus anthracis ames (aka bacillus anthracis str. ames)
L: bacillus thuringiensis subsp. thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
M: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
N: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
O: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
P: bacillus cereus group sp.
Q: bacillus/lactobacillus/streptococcus group (aka bacilli)
R: anthrax bacterium (aka bacillus anthracis)
S: None of the above. | [C; O; R; M] |
<Instruct>: Given the context 'SuperCAT: a supertree database for combined and integrative multilocus sequence typing analysis of the Bacillus cereus group of bacteria (including B. cereus, B. anthracis and B. thuringiensis)
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. cereus; b. anthracis; b. thuringiensis]
<Options>: A: cereus (aka cereus <sea anemones>)
B: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: bacillus cereus (strain atcc 14579 / dsm 31) (aka bacillus cereus atcc 14579)
E: bacillus toyonensis biovar thuringiensis
F: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
G: bacillus subtilis group sp.
H: bacillus cereus group sp.
I: cereus <eudicots> (cereus) (aka cereus <eudicots>)
J: bacillus cereus var. anthracis (aka bacillus anthracis)
K: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
L: bacillus thuringiensis gv. thuringiensis
M: chromobacterium group
N: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
O: bacillus anthracis str. ames ancestor (aka bacillus anthracis str. 'ames ancestor')
P: bacillus cereus group
Q: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
R: anthracus
S: None of the above. | [P; C; J; K] |
<Instruct>: Given the context 'SuperCAT: a supertree database for combined and integrative multilocus sequence typing analysis of the Bacillus cereus group of bacteria (including B. cereus, B. anthracis and B. thuringiensis)
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. cereus; b. anthracis; b. thuringiensis]
<Options>: A: bacillus mojavensis subgroup
B: bacillus anthracis (strain sterne) (aka bacillus anthracis str. sterne)
C: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
D: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
E: bacillus endorhythmos (aka bacillus cereus)
F: vibrio subtilis (aka bacillus subtilis)
G: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
H: bacteridium anthracis (aka bacillus anthracis)
I: bacillus subtilis group sp.
J: bacillus toyonensis biovar thuringiensis
K: bacillus cereus var. anthracis (aka bacillus anthracis)
L: bacillus anthracis strain 'ames ancestor' (aka bacillus anthracis str. 'ames ancestor')
M: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
N: bacillus subtilis group
O: bacillus cereus group
P: anthracus
Q: lycoriella thuringiensis
R: bacillus thuringiensis gv. cytolyticus
S: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
T: None of the above. | [O; E; H; G] |
<Instruct>: Given the context 'SuperCAT: a supertree database for combined and integrative multilocus sequence typing analysis of the Bacillus cereus group of bacteria (including B. cereus, B. anthracis and B. thuringiensis)
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. cereus; b. anthracis; b. thuringiensis]
<Options>: A: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
B: bacillus anthracis strain 'ames ancestor' (aka bacillus anthracis str. 'ames ancestor')
C: bacillus cereus (strain atcc 14579 / dsm 31) (aka bacillus cereus atcc 14579)
D: cereus (aka cereus <sea anemones>)
E: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
F: bacillus cereus biovar anthracis
G: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
H: cereus (aka cereus <eudicots>)
I: bacillus thuringiensis serovar thailandensis
J: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
K: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
L: bacillus cereus group
M: anthracus
N: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
O: bacillus (aka bacillus <firmicutes>)
P: bacillus thuringiensis subsp. nigeriensis (aka bacillus thuringiensis serovar nigeriensis)
Q: anthrax bacterium (aka bacillus anthracis)
R: None of the above. | [L; E; Q; G] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
B: bacteridium anthracis (aka bacillus anthracis)
C: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
D: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
E: anthrax subgroup
F: chromobacterium group
G: bacillus subtilis group
H: bacillus cereus group
I: bacillus thuringiensis serovar kurstaki (bacillus thuringiensis (subsp. kurstaki)) (aka bacillus thuringiensis serovar kurstaki)
J: bacillus thuringiensis gv. thuringiensis
K: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
L: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
M: bacillus thuringiensis thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
N: anthribola
O: cereus (aka cereus <eudicots>)
P: anthracus
Q: bacillus anthracis str. ames ancestor (aka bacillus anthracis str. 'ames ancestor')
R: anthrenus
S: bacillus cereus biovar anthracis
T: None of the above. | [H; B; B; D] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: anthrenus
B: bacillus mojavensis subgroup
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: anthrax bacterium (aka bacillus anthracis)
E: anthribola
F: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
G: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
H: unclassified bacillus cereus group
I: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
J: unclassified anthrax
K: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
L: bacillus thuringiensis gv. cytolyticus
M: bacillus cereus biovar anthracis
N: bacillus (aka bacillus <firmicutes>)
O: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
P: anthrax irroratus
Q: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
R: anthracus
S: bacillus cereus group
T: None of the above. | [S; D; D; F] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
B: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
C: bacillus cereus group
D: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
E: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
F: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
G: lycoriella thuringiensis
H: bacillus mojavensis subgroup
I: bacillus thuringiensis subsp. thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
J: bacillus cereus group sp.
K: anthrax
L: anthrax irroratus
M: anthrax subgroup
N: cereus (aka cereus <eudicots>)
O: limnophora anthrax (aka spilogona anthrax)
P: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
Q: bacillus anthracis (strain ames) (aka bacillus anthracis str. ames)
R: bacillus cereus biovar anthracis
S: None of the above. | [C; A; A; P] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: cereus (aka cereus <eudicots>)
B: bacillus thuringiensis gv. cytolyticus
C: anthracus
D: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
E: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
F: bacillus/lactobacillus/streptococcus group (aka bacilli)
G: anthrax anthrax (musca anthrax) (aka anthrax anthrax)
H: anthrax subgroup
I: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
J: lycoriella thuringiensis
K: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
L: bacillus cereus group
M: anthrenus
N: unclassified bacillus cereus group
O: anthrax
P: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
Q: bacillus thuringiensis subsp. thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
R: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
S: None of the above. | [L; E; E; R] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus]
<Options>: A: bacillus cereus group
B: bacillus cereus var. anthracis (aka bacillus anthracis)
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: cereus <eudicots> (cereus) (aka cereus <eudicots>)
E: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
F: None of the above. | [C] |
<Instruct>: Given the context 'Therefore, we have developed a database that compiles and integrates MLST data from all five schemes for the B. cereus group, accessible at http://mlstoslo.uio.no/. Supertree techniques were used to combine the phylogenetic information from analysis of all schemes and datasets, in order to produce an integrated view of the B. cereus group population.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus/clostridium group (aka bacillota)
B: bacillus mojavensis subgroup
C: bacillus cereus group
D: bacillus cereus group sp.
E: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
F: None of the above. | [C] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: neisseria meningitidis serogroup a (neisseria meningitidis (serogroup a)) (aka neisseria meningitidis serogroup a)
B: micrococcus meningitidis cerebrospinalis (aka neisseria meningitidis)
C: haemophilus ducreyi (aka [haemophilus] ducreyi)
D: streptococcus pasteuri ('streptococcus pasteuri') (aka streptococcus pasteuri)
E: haemophilus parahaemolyticus
F: streptococcus parasuis
G: haemophilus influenzae (haemophilus meningitidis) (aka haemophilus influenzae)
H: streptococcus infantis
I: haemophilus bovis (aka moraxella bovis)
J: streptococcus ovis
K: streptococcus erysipelatos (aka streptococcus pyogenes)
L: streptococcus
M: streptococcus mitis
N: streptococcus hemolyticus (aka streptococcus pyogenes)
O: haemophilus taxon c (haemophilus sp. (strain taxon c)) (aka haemophilus taxon c)
P: diplococcus pneumoniae (aka streptococcus pneumoniae)
Q: neisseria meningitidis group b (aka neisseria meningitidis serogroup b)
R: gonococcus neisseri (aka neisseria gonorrhoeae)
S: neisseria meningitidis serogroup z
T: None of the above. | [B; P; K; G] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: streptococcus hemolyticus (aka streptococcus pyogenes)
B: neisseria meningitidis strain nmb (aka neisseria meningitidis nmb)
C: streptococcus oralis (streptococcus oralis bridge and sneath 1982) (aka streptococcus oralis)
D: haemophilus sp.
E: haemophilus parainfluenzae
F: streptococcus uberis
G: haemobacillus
H: neisseria lactamicus (aka neisseria lactamica)
I: streptococcus sp. (group b) (aka streptococcus sp. 'group b')
J: micrococcus meningitidis cerebrospinalis (aka neisseria meningitidis)
K: haemophilus haemoglobinophilus (aka canicola haemoglobinophilus)
L: mycobacterium influenzae (aka haemophilus influenzae)
M: bacillus pneumoniae (aka klebsiella pneumoniae)
N: streptococcus suis
O: streptococcus parapneumoniae
P: micrococcus pneumoniae (aka streptococcus pneumoniae)
Q: neisseria meningitidis serogroup y
R: micrococcus pyogenes (aka staphylococcus aureus)
S: neisseriaceae bacterium
T: None of the above. | [J; P; A; L] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: haemophilus somnus (aka histophilus somni)
B: streptococcus parapneumoniae
C: neisseria gonorrhoeae (micrococcus der gonorrhoe) (aka neisseria gonorrhoeae)
D: streptococcus ovis
E: micrococcus pneumoniae (aka streptococcus pneumoniae)
F: streptococcus parasuis
G: micrococcus meningitidis cerebrospinalis (aka neisseria meningitidis)
H: neisseria lactamicus (aka neisseria lactamica)
I: streptococcus suis
J: haemobacillus
K: streptococcus pyogenes (streptococcus erysipelatos) (aka streptococcus pyogenes)
L: staphylococcus pyogenes aureus (aka staphylococcus aureus)
M: streptococcus gallolyticus subsp. pasteurianus (aka streptococcus pasteurianus)
N: klebsiella pneumoniae subsp. pneumoniae
O: influenza-bacillus (aka haemophilus influenzae)
P: streptococcus sp. (group b) (aka streptococcus sp. 'group b')
Q: haemophilus parahaemolyticus
R: neisseria meningitidis (serogroup c) (aka neisseria meningitidis serogroup c)
S: haemophilus sp.
T: neisseria meningitidis str. nmb (aka neisseria meningitidis nmb)
U: None of the above. | [G; E; K; O] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: haemophilus bovis (aka moraxella bovis)
B: streptococcus
C: neisseria meningitidis strain nmb (aka neisseria meningitidis nmb)
D: klebsiella pneumoniae subsp. pneumoniae
E: micrococcus meningitidis cerebrospinalis (aka neisseria meningitidis)
F: neisseriaceae bacterium
G: streptococcus pyogenes (streptococcus erysipelatos) (aka streptococcus pyogenes)
H: haemophilus taxon c (haemophilus sp. (strain taxon c)) (aka haemophilus taxon c)
I: streptococcus parasuis
J: neisseria meningitidis group b (aka neisseria meningitidis serogroup b)
K: neisseria meningitidis serogroup z
L: streptococcus mutans
M: haemophilus ducreyi (aka [haemophilus] ducreyi)
N: haemophilus meningitidis (aka haemophilus influenzae)
O: streptococcus pneumoniae (diplococcus pneumoniae) (aka streptococcus pneumoniae)
P: haemophilus parainfluenzae
Q: streptococcus suis
R: streptococcus infantis
S: bacillus pneumoniae (aka klebsiella pneumoniae)
T: None of the above. | [E; O; G; N] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: staphylococcus group (aka staphylococcaceae)
B: staphylococcus sp.
C: burkholderia pseudomallei b03
D: enterococcus faecium (streptococcus faecium) (aka enterococcus faecium)
E: burkholderia pseudomallei (ara+ biotype) (burkholderia siamensis) (aka burkholderia pseudomallei (ara+ biotype))
F: campylobacter pylori (aka helicobacter pylori)
G: staphylococcus aureus str. pa (aka staphylococcus aureus pa)
H: campylobacter-like bacterium
I: campylobacter jejuni jejuni (aka campylobacter jejuni subsp. jejuni)
J: micrococcus aureus (aka staphylococcus aureus)
K: burkholderia pseudomallei dl2
L: campylobacter
M: bacillus pseudomallei (aka burkholderia pseudomallei)
N: enterococcus faecium ef_aus0065
O: staphylococcus aureus subsp. aureus col (staphylococcus aureus col) (aka staphylococcus aureus subsp. aureus col)
P: campylobacter fetus subsp. jejuni (aka campylobacter jejuni)
Q: enterococcus
R: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
S: streptococcus faecalis (aka enterococcus faecalis)
T: enterococcus faecium ef_aus0080
U: None of the above. | [J; P; D; M] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: burkholderia pseudomallei dl2
B: streptococcus faecium (aka enterococcus faecium)
C: enterococcus faecium ef_aus0051
D: staphylococcus sp. s
E: enterococcus faecium ef_aus0050
F: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
G: staphylococcus sp.
H: staphylococcus aureus (staphylococcus aureus subsp. anaerobius) (aka staphylococcus aureus)
I: enterococcus
J: micrococcus epidermidis (aka staphylococcus epidermidis)
K: enterococcus faecium ef_aus0021
L: campylobacteraceae bacterium
M: campylobacter-like bacterium
N: campylobacter gastrosuis
O: staphylococcus group (aka staphylococcaceae)
P: campylobacter jejuni subsp. jejuni (campylobacter jejuni jejuni) (aka campylobacter jejuni subsp. jejuni)
Q: malleomyces pseudomallei (aka burkholderia pseudomallei)
R: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
S: campylobacter jejuni (campylobacter fetus subsp. jejuni) (aka campylobacter jejuni)
T: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
U: None of the above. | [H; S; B; Q] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: pseudomonas pseudomallei (aka burkholderia pseudomallei)
B: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
C: enterococcus
D: burkholderia pseudomallei 5(1949)
E: campylobacter hominis (candidatus campylobacter hominis) (aka campylobacter hominis)
F: enterococcus faecium ef_aus0050
G: enterococcus faecium (streptococcus faecium) (aka enterococcus faecium)
H: campylobacter jejuni subsp. jejuni 1798
I: staphylococcus sp. s
J: campylobacter jejuni (campylobacter fetus subsp. jejuni) (aka campylobacter jejuni)
K: staphylococcus aureus (staphylococcus aureus subsp. anaerobius) (aka staphylococcus aureus)
L: staphylococcus (aurococcus) (aka staphylococcus)
M: campylobacter gastrosuis
N: burkholderia pseudomallei 6(1960)
O: staphylococcus aureus col (aka staphylococcus aureus subsp. aureus col)
P: enterococcus florum
Q: staphylococcus sp.
R: enterococcus faecium e155
S: campylobacteraceae bacterium
T: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
U: None of the above. | [K; J; G; A] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: enterococcus faecium (streptococcus faecium) (aka enterococcus faecium)
B: campylobacter jejuni jejuni (aka campylobacter jejuni subsp. jejuni)
C: enterococcus
D: vibrio jejuni (aka campylobacter jejuni)
E: burkholderia pseudomallei 5(1949)
F: campylobacter jejuni x
G: staphylococcus sp. s
H: campylobacter pylori (aka helicobacter pylori)
I: enterococcus plantarum
J: staphylococcus staphylolyticus (aka staphylococcus simulans bv. staphylolyticus)
K: staphylococcus group (aka staphylococcaceae)
L: micrococcus epidermidis (aka staphylococcus epidermidis)
M: campylobacter jejuni subsp. jejuni str. nw (aka campylobacter jejuni subsp. jejuni nw)
N: burkholderia pseudomallei bdu 2
O: bacillus pseudomallei (aka burkholderia pseudomallei)
P: staphylococcus aureus (staphylococcus aureus subsp. anaerobius) (aka staphylococcus aureus)
Q: enterococcus faecium ef_aus0007
R: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
S: burkholderia pseudomallei 6(1960)
T: enterococcus faecium e155
U: None of the above. | [P; D; A; O] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [escherichia coli; salmonella enterica; bacillus cereus group]
<Options>: A: bacillus subtilis group sp.
B: unclassified bacillus cereus group
C: salmonella enterica serovar choleraesuis (aka salmonella enterica subsp. enterica serovar choleraesuis)
D: salmonella enterica subsp. enterica serovar abortus (salmonella abortus) (aka salmonella enterica subsp. enterica serovar abortus)
E: salmonella enterica subsp. i (aka salmonella enterica subsp. enterica)
F: bacillus cereus group
G: escherichia coli (strain b) (aka escherichia coli b)
H: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
I: bacillus cereus group sp.
J: enterobacterales (enterobacteriaceae and related endosymbionts) (aka enterobacterales)
K: salmonella sp.
L: salmonella enterica (salmonella enterica ser. choleraesuis) (aka salmonella enterica)
M: enterobacteria (aka enterobacteriaceae)
N: enterococcus coli (aka escherichia coli)
O: bacteria (ex cavalier-smith 1987) (aka bacteria)
P: None of the above. | [N; L; F] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [escherichia coli; salmonella enterica; bacillus cereus group]
<Options>: A: salmonella enterica serovar typhimurium (aka salmonella enterica subsp. enterica serovar typhimurium)
B: enterobacteria (aka enterobacteriaceae)
C: salmonella enterica subsp. enterica (salmonella cholerae-suis subsp. cholerae-suis) (aka salmonella enterica subsp. enterica)
D: 'escherichia faecalis' (aka escherichia faecalis)
E: salmonella enterica serovar choleraesuis (aka salmonella enterica subsp. enterica serovar choleraesuis)
F: chromobacterium group
G: escherichia/shigella coli (aka escherichia coli)
H: unspecified coliform bacterium
I: salmonella enterica serovar gallinarum (aka salmonella enterica subsp. enterica serovar gallinarum)
J: bacillus mojavensis subgroup
K: escherichia coli 1a
L: salmonella choleraesuis (aka salmonella enterica)
M: bacillus cereus group
N: bacillus subtilis group sp.
O: bacillus/clostridium group (aka bacillota)
P: None of the above. | [G; L; M] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [escherichia coli; salmonella enterica; bacillus cereus group]
<Options>: A: unclassified bacillus cereus group
B: salmonella enterica serovar gallinarum (aka salmonella enterica subsp. enterica serovar gallinarum)
C: salmonella choleraesuis (aka salmonella enterica)
D: bacillus cereus group
E: salmonella enterica serovar enteritidis (aka salmonella enterica subsp. enterica serovar enteritidis)
F: unspecified coliform bacterium
G: escherichia/shigella coli (aka escherichia coli)
H: salmonella enterica subsp. enterica serovar abortus (salmonella abortus) (aka salmonella enterica subsp. enterica serovar abortus)
I: escherichia
J: bacillus cereus group sp.
K: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
L: bacteria (ex cavalier-smith 1987) (aka bacteria)
M: enterobacteria (aka enterobacteriaceae)
N: salmonella
O: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
P: None of the above. | [G; C; D] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: anthriscus
B: bacillus cereus (strain atcc 14579 / dsm 31) (aka bacillus cereus atcc 14579)
C: bacteridium anthracis (aka bacillus anthracis)
D: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
E: anthrax
F: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
G: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
H: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
I: bacillus anthracis str. 'ames ancestor' (bacillus anthracis strain 'ames ancestor') (aka bacillus anthracis str. 'ames ancestor')
J: anthrenus
K: bacillus sp. (in: firmicutes)
L: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
M: cereus <eudicots> (cereus) (aka cereus <eudicots>)
N: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
O: bacillus mojavensis subgroup
P: anthribola
Q: bacillus cereus group
R: mycobacterium anthracenicum ('mycobacterium anthracenicum') (aka mycobacterium anthracenicum)
S: None of the above. | [Q; C; C; G] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus cereus str. w (aka bacillus cereus w)
B: bacillus cereus (strain atcc 14579 / dsm 31) (aka bacillus cereus atcc 14579)
C: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
D: bacillus cereus biovar anthracis
E: bacillus cereus str. f (aka bacillus cereus f)
F: bacillus/clostridium group (aka bacillota)
G: bacteridium anthracis (aka bacillus anthracis)
H: anthribus
I: bacillus cereus group
J: cereus (aka cereus <eudicots>)
K: unclassified anthrax
L: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
M: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
N: bacillus sp. (in: firmicutes)
O: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
P: bacillus anthracis (strain ames) (aka bacillus anthracis str. ames)
Q: anthrax anthrax (musca anthrax) (aka anthrax anthrax)
R: None of the above. | [I; G; G; M] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
B: bacillus cereus str. w (aka bacillus cereus w)
C: anthrenus
D: vibrio subtilis (aka bacillus subtilis)
E: bacillus/clostridium group (aka bacillota)
F: anthrax varius
G: bacillus cereus group
H: bacillus mojavensis subgroup
I: anthrax
J: bacillus endorhythmos (aka bacillus cereus)
K: bacillus cereus biovar anthracis
L: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
M: lasiancistrus anthrax (aka pseudolithoxus anthrax)
N: bacillus cereus group sp.
O: anthracus
P: anthriscus
Q: bacillus subtilis group
R: anthrax (aka bacillus anthracis)
S: chromobacterium group
T: None of the above. | [G; R; R; J] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus mojavensis subgroup
B: bacillus subtilis group sp.
C: bacillus cereus biovar anthracis
D: bacillus subtilis group
E: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
F: anthribola
G: bacillus cereus group
H: unclassified anthrax
I: bacteridium anthracis (aka bacillus anthracis)
J: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
K: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
L: limnophora anthrax (aka spilogona anthrax)
M: vibrio subtilis (aka bacillus subtilis)
N: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
O: anthrax varius
P: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
Q: bacillus cereus var. anthracis (aka bacillus anthracis)
R: bacillus anthracis ames "ancestor" (aka bacillus anthracis str. 'ames ancestor')
S: None of the above. | [G; I; I; N] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus mojavensis subgroup
B: bacillus subtilis group sp.
C: anthribola
D: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
E: bacillus anthracis ames "ancestor" (aka bacillus anthracis str. 'ames ancestor')
F: bacillus subtilis group
G: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
H: anthrax varius
I: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
J: bacteridium anthracis (aka bacillus anthracis)
K: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
L: vibrio subtilis (aka bacillus subtilis)
M: bacillus cereus var. anthracis (aka bacillus anthracis)
N: limnophora anthrax (aka spilogona anthrax)
O: bacillus cereus biovar anthracis
P: unclassified anthrax
Q: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
R: None of the above. | [R; J; J; Q] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
B: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
C: bacillus thuringiensis gv. thuringiensis
D: mammals (aka mammalia)
E: luteimonas weifangensis (aka cognatiluteimonas weifangensis)
F: baccharis weirii
G: bacillus weihenstephanensis (aka bacillus mycoides)
H: cellular organisms (biota) (aka cellular organisms)
I: bacillus toyonensis biovar thuringiensis
J: helicobacter kumamotonensis
K: spongicoloides weijiaensis
L: macrobiotus sapiens
M: human (aka homo sapiens)
N: this
O: lycoriella thuringiensis
P: None of the above. | [M; A; G] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; b. thuringiensis; b. weihenstephanensis]
<Options>: A: stegana weiqiuzhangi
B: bacillus weihenstephanensis (aka bacillus mycoides)
C: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
D: species
E: bacillus thuringiensis serovar kurstaki (bacillus thuringiensis (subsp. kurstaki)) (aka bacillus thuringiensis serovar kurstaki)
F: bacillus thuringiensis serovar thailandensis
G: pseudomonas weihenstephanensis
H: primate (aka primates)
I: mammals (aka mammalia)
J: bacillus thuringiensis gv. thuringiensis
K: kingdom
L: homo sapiens (human) (aka homo sapiens)
M: alsophila weidenbrueckii (aka alsophila weidenbrueckiae)
N: bacillus toyonensis biovar thuringiensis
O: baccharis weirii
P: None of the above. | [L; C; B] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
B: helicobacter kumamotonensis
C: henneguya weishanensis
D: cellular organisms (biota) (aka cellular organisms)
E: human (aka homo sapiens)
F: species
G: bacillus weihenstephanensis (aka bacillus mycoides)
H: lycoriella thuringiensis
I: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
J: homo (humans) (aka homo)
K: bacillus thuringiensis gv. thuringiensis
L: steccherinum weishanense
M: bacillus weihenstephanensis dsm 11821 (aka bacillus mycoides nbrc 101238 = dsm 11821)
N: bacillus thuringiensis serovar kurstaki (bacillus thuringiensis (subsp. kurstaki)) (aka bacillus thuringiensis serovar kurstaki)
O: genus
P: None of the above. | [E; I; G] |
<Instruct>: Given the context 'Unlike other bacterial species that are typed using a single MLST scheme, five separate schemes have been developed for the B. cereus group, based on different sets of genes and isolates (5–10).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus subtilis group
B: bacillus cereus group
C: chromobacterium group
D: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
E: bacillus subtilis group sp.
F: None of the above. | [B] |
<Instruct>: Given the context 'Unlike other bacterial species that are typed using a single MLST scheme, five separate schemes have been developed for the B. cereus group, based on different sets of genes and isolates (5–10).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus subtilis group sp.
B: chromobacterium group
C: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
D: bacillus subtilis group
E: None of the above. | [E] |
<Instruct>: Given the context 'Studies with the various schemes have independently indicated that the B. cereus group population is divided into three main phylogenetic clusters and that species are usually intermixed within the groups.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus/clostridium group (aka bacillota)
B: unclassified bacillus cereus group
C: cereus (aka cereus <eudicots>)
D: bacillus cereus group
E: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
F: None of the above. | [D] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: bacillus endorhythmos (aka bacillus cereus)
B: bacillus cereus str. w (aka bacillus cereus w)
C: bacillus toyonensis biovar thuringiensis
D: anthrax
E: bacillus thuringiensis thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
F: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
G: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
H: bacillus cereus (strain atcc 14579 / dsm 31) (aka bacillus cereus atcc 14579)
I: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
J: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
K: bacillus cereus biovar anthracis
L: bacillus cereus strain f (aka bacillus cereus f)
M: bacillus thuringiensis subsp. nigeriensis (aka bacillus thuringiensis serovar nigeriensis)
N: bacillus anthracis ames (aka bacillus anthracis str. ames)
O: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
P: None of the above. | [O; A; I] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: lycoriella thuringiensis
B: anthrax
C: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
D: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
E: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
F: bacillus cereus strain f (aka bacillus cereus f)
G: bacillus endorhythmos (aka bacillus cereus)
H: bacillus thuringiensis gv. thuringiensis
I: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
J: anthrax bacterium (aka bacillus anthracis)
K: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
L: cereus <eudicots> (cereus) (aka cereus <eudicots>)
M: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
N: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
O: bacillus anthracis ames "ancestor" (aka bacillus anthracis str. 'ames ancestor')
P: None of the above. | [J; G; C] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
B: anthrax
C: bacillus cereus group
D: cereus (aka cereus <eudicots>)
E: bacillus cereus str. w (aka bacillus cereus w)
F: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
G: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
H: bacillus toyonensis biovar thuringiensis
I: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
J: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
K: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
L: anthrax (aka bacillus anthracis)
M: lycoriella thuringiensis
N: mycobacterium anthracenicum ('mycobacterium anthracenicum') (aka mycobacterium anthracenicum)
O: bacillus anthracis ames (aka bacillus anthracis str. ames)
P: None of the above. | [L; F; G] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: anthrax
B: bacillus cereus str. w (aka bacillus cereus w)
C: lycoriella thuringiensis
D: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
E: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
F: bacillus cereus group
G: bacillus anthracis ames (aka bacillus anthracis str. ames)
H: mycobacterium anthracenicum ('mycobacterium anthracenicum') (aka mycobacterium anthracenicum)
I: anthrax (aka bacillus anthracis)
J: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
K: cereus (aka cereus <eudicots>)
L: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
M: bacillus toyonensis biovar thuringiensis
N: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
O: None of the above. | [I; O; E] |
<Instruct>: Given the context 'A second heterogeneous cluster includes B. cereus and B. thuringiensis isolates from various origins, while cold-tolerant B. weihenstephanensis and B. cereus isolates belong to the third group.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
B: spongicoloides weijiaensis
C: bacillus thuringiensis serovar brasilensis (bacillus thuringiensis serovar brasiliensis) (aka bacillus thuringiensis serovar brasilensis)
D: henneguya weishanensis
E: bacillus cereus group sp.
F: bacillus weihenstephanensis (aka bacillus mycoides)
G: listeria weihenstephanensis (paenilisteria weihenstephanensis) (aka listeria weihenstephanensis)
H: bacillus thuringiensis subsp. thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
I: bacillus thuringiensis serovar kurstaki (bacillus thuringiensis (subsp. kurstaki)) (aka bacillus thuringiensis serovar kurstaki)
J: bacillus weihaiensis
K: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
L: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
M: bacillus cereus strain f (aka bacillus cereus f)
N: vibrio subtilis (aka bacillus subtilis)
O: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
P: None of the above. | [A; L; F] |
<Instruct>: Given the context 'A second heterogeneous cluster includes B. cereus and B. thuringiensis isolates from various origins, while cold-tolerant B. weihenstephanensis and B. cereus isolates belong to the third group.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus weihenstephanensis (aka bacillus mycoides)
B: baccharis weirii
C: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
D: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
E: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
F: pseudomonas weihenstephanensis
G: bacillus cereus strain f (aka bacillus cereus f)
H: lycoriella thuringiensis
I: bacillus thuringiensis gv. cytolyticus
J: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
K: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
L: cereus (aka cereus <eudicots>)
M: bacillus weihaiensis
N: bacillus weihenstephanensis dsm 11821 (aka bacillus mycoides nbrc 101238 = dsm 11821)
O: bacillus cereus group
P: None of the above. | [J; K; A] |
<Instruct>: Given the context 'A second heterogeneous cluster includes B. cereus and B. thuringiensis isolates from various origins, while cold-tolerant B. weihenstephanensis and B. cereus isolates belong to the third group.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
B: bacillus cereus biovar anthracis
C: baccharis weirii
D: bacillus weihenstephanensis (aka bacillus mycoides)
E: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
F: pseudomonas weihenstephanensis
G: spongicoloides weijiaensis
H: bacillus thuringiensis serovar wuhanensis (bacillus thuringiensis subsp. wuhanensis) (aka bacillus thuringiensis serovar wuhanensis)
I: bacillus thuringiensis gv. thuringiensis
J: bacillus cereus strain f (aka bacillus cereus f)
K: bacillus thuringiensis thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
L: cereus (aka cereus <sea anemones>)
M: bacillus cereus str. w (aka bacillus cereus w)
N: bacillus endorhythmos (aka bacillus cereus)
O: lycoriella thuringiensis
P: None of the above. | [N; A; D] |
<Instruct>: Given the context 'The separate MLST analyses have also revealed that the B. cereus group population is weakly clonal overall due to numerous clinical and virulent isolates emerging from different phylogenetic positions (5–8,11–14), with the exception of the ‘cold-tolerant’ cluster that seems to exhibit a panmictic (or sexual) population structure, i.e. with frequent genetic exchanges between strains (9).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus (aka cereus <sea anemones>)
B: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
C: bacillus subtilis group
D: bacillus cereus group
E: bacillus/clostridium group (aka bacillota)
F: None of the above. | [D] |
<Instruct>: Given the context 'The separate MLST analyses have also revealed that the B. cereus group population is weakly clonal overall due to numerous clinical and virulent isolates emerging from different phylogenetic positions (5–8,11–14), with the exception of the ‘cold-tolerant’ cluster that seems to exhibit a panmictic (or sexual) population structure, i.e. with frequent genetic exchanges between strains (9).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus (aka cereus <sea anemones>)
B: bacillus/clostridium group (aka bacillota)
C: bacillus subtilis group
D: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
E: None of the above. | [E] |
<Instruct>: Given the context 'Here, in order to provide the B. cereus group research community with a common MLST resource, we have developed on the same website a database, SuperCAT, that compiles and integrates MLST data from all the published B. cereus group schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus (aka cereus <eudicots>)
B: bacillus cereus group
C: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
D: bacillus/clostridium group (aka bacillota)
E: chromobacterium group
F: None of the above. | [B] |
<Instruct>: Given the context 'In addition, we applied supertree reconstruction methods to build an integrated view of the B. cereus group population and phylogeny.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
B: bacillus sp. (in: firmicutes)
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: bacillus cereus group
E: chromobacterium group
F: None of the above. | [D] |
<Instruct>: Given the context 'The SuperCAT database provides information, sequence and phylogenetic data for all bacterial isolates that have been typed using any of the five published MLST schemes for the B. cereus group (Table 1).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
B: bacillus cereus group
C: bacillus/clostridium group (aka bacillota)
D: bacillus cereus str. f (aka bacillus cereus f)
E: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
F: None of the above. | [B] |
<Instruct>: Given the context 'SuperCAT also contains the phylogenetic supertree of the B. cereus group reconstructed by combining the sequence data from all five schemes, as well as supertrees built for individual schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
B: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
C: bacillus cereus group
D: bacillus cereus group sp.
E: bacillus subtilis group
F: None of the above. | [C] |
<Instruct>: Given the context 'In addition, sequences of all MLST loci were extracted from the complete genomes of the 21 sequenced B. cereus group strains available in Genbank.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: chromobacterium group
B: bacillus cereus group
C: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
D: cereus (aka cereus <eudicots>)
E: bacillus subtilis group
F: None of the above. | [B] |
<Instruct>: Given the context 'Table 1.The five MLST schemes designed for typing bacteria of the B. cereus groupSchemeGenesTotal sequence length (bp)Total number of isolateseUsed in (references)Helgasonadk, ccpA, ftsA, glpT, pyre, recF and sucC2 938120(6,12,46)Candelon–Sorokina,cclpC, dinB, gdpD, panC, purF and yhfL2 850149(9,10)Kob,cgyrB, mbl, mdh, mutS, pycA(1) and rpoB2 00265(7)Priesta,bglpF, gmk, ilvD, pta, purH, pycA(2) and tpi2 829721(8,11,13–15,46–48)Tourasse–Helgasona,b,dadk, ccpA, glpF, glpT, panC, pta and pycA(2)2 658172(5)aSpecific databases for the Priest and Tourasse–Helgason schemes are accessible at http://pubmlst.org/bcereus/ and http://mlstoslo.uio.no/, respectively.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: chromobacterium group
B: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
C: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
D: bacillus cereus group
E: cereus <eudicots> (cereus) (aka cereus <eudicots>)
F: None of the above. | [D] |
<Instruct>: Given the context 'A BLAST database for the Candelon–Sorokin scheme is available at http://spock.jouy.inra.fr/cgi-bin/bacilliMLSopen.cgi.bWhile the Tourasse–Helgason and Priest schemes use the same gene fragment for the pycA gene, the Ko scheme is based on a different and non-overlapping gene region.cThe B. cereus group-specific transcriptional regulator plcR was originally included in the Candelon–Sorokin and Ko schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
B: bacillus subtilis group
C: bacillus cereus group
D: unclassified bacillus cereus group
E: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
F: None of the above. | [C] |
<Instruct>: Given the context 'In this study, the 21 B. cereus group strains that have been completely sequenced, and for which the sequences at all 26 MLST loci are thus available, can be used to join all five schemes and provide the strain overlap necessary for supertree analysis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
B: bacillus cereus group
C: cereus (aka cereus <sea anemones>)
D: chromobacterium group
E: unclassified bacillus cereus group
F: None of the above. | [B] |
<Instruct>: Given the context 'The global B. cereus group supertree, containing 1029 isolates, was reconstructed according to the widely used matrix representation by parsimony (MRP) procedure (Figure 1; (19,25,26)).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus mojavensis subgroup
B: bacillus cereus group
C: cereus (aka cereus <sea anemones>)
D: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
E: unclassified bacillus cereus group
F: None of the above. | [B] |
<Instruct>: Given the context 'Figure 1.Schematic overview of the B. cereus group supertree reconstruction procedure using Matrix Representation by Parsimony (MRP).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
B: cereus (aka cereus <eudicots>)
C: bacillus subtilis group
D: bacillus mojavensis subgroup
E: bacillus cereus group
F: None of the above. | [E] |
<Instruct>: Given the context 'Figure 1.Schematic overview of the B. cereus group supertree reconstruction procedure using Matrix Representation by Parsimony (MRP).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
B: bacillus mojavensis subgroup
C: cereus (aka cereus <eudicots>)
D: bacillus subtilis group
E: None of the above. | [E] |
<Instruct>: Given the context 'It should be noted that the global 1029-strain supertree retains the phylogenetic signals from the individual schemes and contains the three main clusters of the B. cereus group population described in the section ‘Introduction’.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
B: bacillus cereus group
C: bacillus cereus strain f (aka bacillus cereus f)
D: bacillus sp. (in: firmicutes)
E: bacillus cereus group sp.
F: None of the above. | [B] |
<Instruct>: Given the context 'These 21 isolates cover all three clusters, although the majority of them are B. anthracis strains or clinical strains closely related to B. anthracis due to the focus of genome sequencing projects, making the part of the supertree containing these isolates likely to be more accurate than the rest of the tree.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis]
<Options>: A: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
B: bacillus anthracis (strain sterne) (aka bacillus anthracis str. sterne)
C: bacillus anthracis (strain ames) (aka bacillus anthracis str. ames)
D: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
E: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
F: None of the above. | [D] |
<Instruct>: Given the context 'Precise within-cluster groupings may contain more uncertainty, as indicated by the large number of unresolved multifurcations in the B. cereus group supertree.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: unclassified bacillus cereus group
B: bacillus cereus group
C: cereus (aka cereus <eudicots>)
D: bacillus cereus strain f (aka bacillus cereus f)
E: cereus (aka cereus <sea anemones>)
F: None of the above. | [B] |
<Instruct>: Given the context 'Apart from the basic functions for selecting and accessing strain information and sequence data for all five B. cereus group MLST schemes, the main features of SuperCAT relate to the manipulation of the supertrees constructed by the MRP approach.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group
B: bacillus mojavensis subgroup
C: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
D: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
E: cereus (aka cereus <sea anemones>)
F: None of the above. | [A] |
<Instruct>: Given the context 'The global supertree based on the combination of all five B. cereus group MLST schemes as well as the five scheme-specific supertrees can be browsed according to various user-chosen criteria (Figure 2).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group
B: bacillus/clostridium group (aka bacillota)
C: cereus (aka cereus <sea anemones>)
D: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
E: bacillus cereus group sp.
F: None of the above. | [A] |
<Instruct>: Given the context 'DISCUSSION AND FUTURE DEVELOPMENTS
SuperCAT is a newly created database devoted to the B. cereus group of bacteria whose main objectives are to provide a common MLST repository and means for building a comprehensive genetic analysis of the group that has been typed by five separate schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus/clostridium group (aka bacillota)
B: unclassified bacillus cereus group
C: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
D: bacillus cereus group
E: cereus (aka cereus <sea anemones>)
F: None of the above. | [D] |
<Instruct>: Given the context 'In particular, a new improved method has recently been developed for taking into account both nucleotide substitutions and recombination events in phylogenies, as part of the ClonalFrame software, which has been applied to the B. cereus group and the Priest scheme (38).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus (aka cereus <eudicots>)
B: bacillus subtilis group sp.
C: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
D: bacillus cereus group
E: bacillus cereus group sp.
F: None of the above. | [D] |
<Instruct>: Given the context 'As MLEE, AFLP and MLST have different levels of resolution, one can hope that combining them might provide an even more robust supertree for the B. cereus group.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus sp. (in: firmicutes)
B: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
C: bacillus subtilis group sp.
D: bacillus cereus group
E: bacillus mojavensis subgroup
F: None of the above. | [D] |
<Instruct>: Given the context 'RESULTS AND DISCUSSION Potential cytotoxic activity of synthesized fused isoxazolines 1 and 2 was tested in vitro on four monolayer tumor cell lines: MG-22A (mouse hepatoma), HT-1080 (human fibroblastoma), B16 (mouse melanoma), Neuro 2A (mouse neiroblastoma).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse; human]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: mus sp. (mice (aka mus sp.))
C: kingdom
D: primate (aka primates)
E: peromyscus
F: probles
G: mouse (aka mus musculus)
H: birds (aka aves)
I: mus cricetus (aka cricetus cricetus)
J: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
K: None of the above. | [G; A] |
<Instruct>: Given the context 'RESULTS AND DISCUSSION Potential cytotoxic activity of synthesized fused isoxazolines 1 and 2 was tested in vitro on four monolayer tumor cell lines: MG-22A (mouse hepatoma), HT-1080 (human fibroblastoma), B16 (mouse melanoma), Neuro 2A (mouse neiroblastoma).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse; human]
<Options>: A: primate (aka primates)
B: mus sp. (mice (aka mus sp.))
C: birds (aka aves)
D: mouse (aka mus musculus)
E: probles
F: peromyscus
G: mus cricetus (aka cricetus cricetus)
H: kingdom
I: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
J: None of the above. | [D; J] |
<Instruct>: Given the context 'RESULTS AND DISCUSSION Potential cytotoxic activity of synthesized fused isoxazolines 1 and 2 was tested in vitro on four monolayer tumor cell lines: MG-22A (mouse hepatoma), HT-1080 (human fibroblastoma), B16 (mouse melanoma), Neuro 2A (mouse neiroblastoma).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse; human]
<Options>: A: mice (aka mus sp.) (aka mus sp.)
B: mus cricetus (aka cricetus cricetus)
C: species
D: animals (aka metazoa)
E: this
F: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
G: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
H: homo sapiens (human) (aka homo sapiens)
I: placental mammals (aka eutheria)
J: house mouse (aka mus musculus)
K: None of the above. | [J; H] |
<Instruct>: Given the context 'Introduction
Since the early 1970s, the human major histocompatibility complex (MHC) has been shown to be associated with a number of autoimmune, inflammatory, and infectious diseases, and it continues to be the focus of intense research [1].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: avian (aka aves)
B: kingdom
C: primate (aka primates)
D: humans (aka homo)
E: human (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'The classical class I and class II loci encode the human leucocyte antigen (HLA) proteins involved in antigen presentation to T cells, initiating the adaptive immune response.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: genus
B: human (aka homo sapiens)
C: birds (aka aves)
D: species
E: macrobiotus sapiens
F: None of the above. | [B] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: menevia
B: menella
C: suborder
D: gallus
E: human (aka homo sapiens)
F: birds (aka aves)
G: menosira
H: probles
I: mouse (aka mus musculus)
J: homo (humans) (aka homo)
K: menida
L: species
M: menaethius
N: None of the above. | [E; E; E] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: meneristes
B: species
C: human (aka homo sapiens)
D: menecles
E: mammals (aka mammalia)
F: mus <subgenus> (mus (aka mus <subgenus>))
G: menesia
H: mouse (aka mus musculus)
I: kingdom
J: menoidium
K: menneus
L: this
M: None of the above. | [C; C; C] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: mammals (aka mammalia)
B: this
C: mouse (aka mus musculus)
D: menneus
E: meneristes
F: mus <subgenus> (mus (aka mus <subgenus>))
G: species
H: menesia
I: menoidium
J: kingdom
K: menecles
L: None of the above. | [L; L; L] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: homo (humans) (aka homo)
B: menaethius
C: species
D: genus
E: avian (aka aves)
F: this
G: human (aka homo sapiens)
H: meneristes
I: eutherian mammals (aka eutheria)
J: chicken (aka gallus gallus)
K: menecleonus
L: menesia
M: menetes
N: macrobiotus sapiens
O: None of the above. | [G; G; G] |
<Instruct>: Given the context 'A role for another class III gene, tumour necrosis factor alpha (TNF), in SLE was suggested following the observation that the lupus-prone New Zealand F1 mouse hybrid exhibits constitutively low TNF expression [10].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus <subgenus> (mus (aka mus <subgenus>))
B: mouse (aka mus <genus>)
C: mice (aka mus sp.) (aka mus sp.)
D: mus musculus (house mouse) (aka mus musculus)
E: western european house mouse (aka mus musculus domesticus)
F: None of the above. | [D] |
<Instruct>: Given the context 'Recently, the development of antinuclear antibodies in patients treated with TNF antagonists has also stimulated interest in the possible role of TNF in SLE [11–13].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: mus musculus (house mouse) (aka mus musculus)
B: humans (aka homo)
C: human (aka homo sapiens)
D: subsection
E: goes
F: None of the above. | [C] |
<Instruct>: Given the context 'Murine and human candidate gene studies, together with genome-wide linkage screens, provide further support that multiple genetic loci, including the mouse MHC complex H2 and the human MHC locus, contribute to disease susceptibility [14–17].
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; mouse]
<Options>: A: this
B: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
C: animals (aka metazoa)
D: mouse (aka mus <genus>)
E: western european house mouse (aka mus musculus domesticus)
F: mus cricetus (aka cricetus cricetus)
G: homo sapiens (human) (aka homo sapiens)
H: house mouse (aka mus musculus)
I: macrobiotus sapiens
J: birds (aka aves)
K: None of the above. | [G; H] |
<Instruct>: Given the context 'Murine and human candidate gene studies, together with genome-wide linkage screens, provide further support that multiple genetic loci, including the mouse MHC complex H2 and the human MHC locus, contribute to disease susceptibility [14–17].
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; mouse]
<Options>: A: kingdom
B: mus domesticus (aka mus musculus domesticus)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: genus
E: peromyscus
F: mus cricetus (aka cricetus cricetus)
G: house mouse (aka mus musculus)
H: animals (aka metazoa)
I: homo sapiens (human) (aka homo sapiens)
J: eutherian mammals (aka eutheria)
K: None of the above. | [I; G] |
<Instruct>: Given the context 'It should be noted that the human MHC was first associated with SLE in 1971, when studies demonstrated that lupus probands were enriched for the class I alleles HL-A8 (now known as HLA-B8) and HLA-W15 (now known as HLA-B15) when compared with healthy controls [18,19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: mammals (aka mammalia)
B: homo sapiens (human) (aka homo sapiens)
C: cellular organisms (biota) (aka cellular organisms)
D: macrobiotus sapiens
E: this
F: None of the above. | [B] |
<Instruct>: Given the context 'It should be noted that the human MHC was first associated with SLE in 1971, when studies demonstrated that lupus probands were enriched for the class I alleles HL-A8 (now known as HLA-B8) and HLA-W15 (now known as HLA-B15) when compared with healthy controls [18,19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: mammals (aka mammalia)
B: macrobiotus sapiens
C: cellular organisms (biota) (aka cellular organisms)
D: this
E: None of the above. | [E] |
<Instruct>: Given the context 'This SNP is located within intron 6 of the class III gene, superkiller viralicidic activity 2-like (Saccharomyces cerevisiae) (SKIV2L), and is located approximately 500 kb telomeric to the HLA-DRB1 gene.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [saccharomyces cerevisiae]
<Options>: A: saccharomyces cerevisiae x saccharomyces mikatae
B: saccharomyces albicans (aka candida albicans)
C: saccharomyces cf. cerevisiae
D: saccharomyces sp.
E: brewer's yeast (aka saccharomyces cerevisiae)
F: None of the above. | [E] |
<Instruct>: Given the context 'Analysis of these data (Figure 4) suggests the presence of short-range LD around our associated variant, rs419788, in CEPH families, encompassing approximately 40 kb of the genome which includes the five genes: complement factor B (CFB), RD RNA binding protein (RDBP), SKIV2L, dom-3 homolg Z (C. elegans) (DOM3Z), and serine/threonine kinase 19 (STK19), and does not include the complement C4 locus.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [c. elegans]
<Options>: A: bactris elegans
B: caenorhabditis drosophilae (rhabditis drosophilae) (aka caenorhabditis drosophilae)
C: gongylostoma elegans elegans (clausilia elegans elegans) (aka gongylostoma elegans elegans)
D: caenorhabditis vulgaris (aka caenorhabditis remanei)
E: caenorhabditis elegans (rhabditis elegans) (aka caenorhabditis elegans)
F: None of the above. | [E] |
<Instruct>: Given the context 'The function of Dom3z is currently unknown, although the homologous yeast protein binds nuclear exoribonuclease.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: candida/saccharomycetales (aka candida/saccharomycales clade)
B: saccharomyces cerevisiae (saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883) (aka saccharomyces cerevisiae)
C: saccharomyces cerevisiae or paradoxus (aka saccharomyces cf. cerevisiae/paradoxus)
D: saccharomyces hansenii (aka debaryomyces hansenii)
E: saccharomyces cf. cerevisiae
F: None of the above. | [B] |
<Instruct>: Given the context 'All study participants are European Caucasian on the basis of grandparental origin.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [participants]
<Options>: A: birds (aka aves)
B: athletes
C: homo sapiens (human) (aka homo sapiens)
D: assessor
E: cohort
F: None of the above. | [C] |
<Instruct>: Given the context 'Written consent was obtained from all study participants and ethical approval for this study was obtained from the Multi-Centre Research Ethics Committee (MREC 2 June 1998).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [participants]
<Options>: A: human (aka homo sapiens)
B: assessor
C: genus
D: other (aka unidentified)
E: species
F: None of the above. | [A] |
<Instruct>: Given the context 'Supporting Information
Accession Numbers
The Online Mendelian Inheritance in Man (OMIM, http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim) accession numbers for the genes described in this study are as follows: AGER, 600214; BAT3, 142590; C4A, 120810; C4B, 120820; CFB, 138470; DOM3Z, 605996; DOM3Z, 605996; EHMT2, 604599; HLA-B, 142830; HLA-DPB2, 120290; HLA-DQA1, 146880; HLA-DQB1, 604305; HLA-DRA, 142860; HLA-DRB1, 142857; KIAA1949, 610990; MICA, 600169; NOTCH4, 164951; RDBP, 154040; RDBP, 154040; SKIV2L, 600478; SLC44A4, 606107; STK19, 604977; STK19, 604977; TNF, 191160; and TNXB, 600985.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: mus (aka mus <subgenus>) (aka mus <subgenus>)
C: species
D: macrobiotus sapiens
E: mus <genus> (mice (aka mus <genus>))
F: None of the above. | [A] |
<Instruct>: Given the context 'Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
Abstract
Background
The presence of ERα is the basis for treating breast cancer patients with targeted molecular therapies that block estrogen stimulation of breast cancer cell division.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: species
B: homo sapiens (human) (aka homo sapiens)
C: circe
D: homo (humans) (aka homo)
E: suborder
F: None of the above. | [B] |
<Instruct>: Given the context 'To select patients for the above therapies, currently, the ERα presence in breast cancer tissues is determined in clinical laboratories by microscopically scoring the slides subjected to immunohistochemistry (IHC).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: circe
B: homo sapiens (human) (aka homo sapiens)
C: theraps
D: humans (aka homo)
E: other (aka unidentified)
F: None of the above. | [B] |
<Instruct>: Given the context 'Background
Breast cancer is the most diagnosed and the second leading cause of cancer deaths for women in the United States striking about 300,000 and killing about 40,000 women a year [1].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [women]
<Options>: A: infraclass
B: this
C: species
D: latina
E: human (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'Because endogenous estrogens directly promote the growth of breast cancer cells, estrogen deprivation either by inhibiting its biosynthesis (aromatase inhibitors) or blocking estrogen-mediated gene transcription (tamoxifen) through its high affinity receptor, the estrogen receptor alpha (ERα), are the primary lines of therapy for breast cancer patients.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: theraps
C: cancer
D: this
E: other (aka unidentified)
F: None of the above. | [A] |
<Instruct>: Given the context 'Because endogenous estrogens directly promote the growth of breast cancer cells, estrogen deprivation either by inhibiting its biosynthesis (aromatase inhibitors) or blocking estrogen-mediated gene transcription (tamoxifen) through its high affinity receptor, the estrogen receptor alpha (ERα), are the primary lines of therapy for breast cancer patients.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: this
B: other (aka unidentified)
C: cancer
D: theraps
E: None of the above. | [E] |
<Instruct>: Given the context 'Currently, only those patients who express ERα in their tumors are chosen for aromatase inhibitor or tamoxifen therapies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: circe
B: theraps
C: mouse (aka mus musculus)
D: probles
E: human (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'The patients who express ERα in their tumors have an overall longer cancer-free survival and lower recurrence rates than patients who do not express this receptor [3].
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: suborder
B: cancer
C: mouse (aka mus musculus)
D: homo sapiens (human) (aka homo sapiens)
E: subsection
F: None of the above. | [D] |
<Instruct>: Given the context 'To predict prognosis and identify patients for the above two anti-estrogen therapies, every breast cancer tissue is currently screened for the presence of ERα before a treatment regimen is selected for any breast cancer patient.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients; patient]
<Options>: A: mouse (aka mus musculus)
B: human (aka homo sapiens)
C: probles
D: kingdom
E: isolate
F: species
G: theraps
H: circe
I: None of the above. | [B; B] |
<Instruct>: Given the context 'To predict prognosis and identify patients for the above two anti-estrogen therapies, every breast cancer tissue is currently screened for the presence of ERα before a treatment regimen is selected for any breast cancer patient.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients; patient]
<Options>: A: species
B: isolate
C: goes
D: subsection
E: probles
F: theraps
G: homo sapiens (human) (aka homo sapiens)
H: data
I: None of the above. | [G; G] |
<Instruct>: Given the context 'Our rational for establishing a cut off value is that any patient who expresses above the cut off level could be selected as a candidate for anti-estrogen therapies and could be considered to have good prognosis.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patient]
<Options>: A: circe
B: genus
C: human (aka homo sapiens)
D: theraps
E: subsection
F: None of the above. | [C] |
<Instruct>: Given the context 'Based on our data above any patient who has more than 5 × 106 copies per 1010 GAPDH copies in her tumor tissue could be considered positive for ERα, could be selected for anti-estrogen therapies and considered to have good prognosis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patient]
<Options>: A: isolate
B: proxys
C: human (aka homo sapiens)
D: probles
E: species
F: None of the above. | [C] |
<Instruct>: Given the context 'Further studies on partially purified calf thymus DNA polymerase a.
Abstract
Attempts to prevent the urea conversion of a 200-230,000 molecular weight DNA polymerase alpha to a 150-170,000 molecular weight form by the inclusion of protease inhibitors have not been successful.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: sueus
B: bos bovis (aka bos taurus)
C: veturius
D: gallus
E: equetus
F: None of the above. | [B] |
<Instruct>: Given the context 'Volume 6 Number 10 1979
Nucleic Acids Research
Further studies on partially purified calf thymus DNA polymerase a Keith McKune and Andrew M.Holmes*
Biochemistry Department, Strathclyde University, The Todd Centre, 31 Taylor Street, Glasgow, G4 ONR, UK
Received I June 1979 ABSTRACT
Attempts to prevent the urea conversion of a 200-230, 000 molecular weight DNA polymerase a to a 150-170, 000 molecular weight form by the
inclusion of protease inhibitors have not been successful.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: horse (aka equus caballus)
B: veturius
C: equus subg. hemionus (aka equus)
D: bos bovis (aka bos taurus)
E: gallus
F: None of the above. | [D] |
<Instruct>: Given the context 'Volume 6 Number 10 1979
Nucleic Acids Research
Further studies on partially purified calf thymus DNA polymerase a Keith McKune and Andrew M.Holmes*
Biochemistry Department, Strathclyde University, The Todd Centre, 31 Taylor Street, Glasgow, G4 ONR, UK
Received I June 1979 ABSTRACT
Attempts to prevent the urea conversion of a 200-230, 000 molecular weight DNA polymerase a to a 150-170, 000 molecular weight form by the
inclusion of protease inhibitors have not been successful.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: equus subg. hemionus (aka equus)
B: gallus
C: horse (aka equus caballus)
D: veturius
E: None of the above. | [E] |
<Instruct>: Given the context 'INTRODUCTION
In mammals DNA polymerase a is thought to be the replicative
enzyme, but due to low levels of activity, even in tissues actively making DNA, and to enzyme heterogeneity it has been found difficult to purify
However, small samples of DNA polymerase a have been highly purified
2, 3, 4, 5 from several sources and partially characterised
Heterogeneity has been observed in DNA polymerase a from a var
6 7
iety of sources, including rat liver and spleen , Hela cells, baby hamster
8 9, 10 11
kidney cells , mouse myeloma , Drosophila embryos and calf thymus
1,6, 12, 13 .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse; drosophila; calf]
<Options>: A: veturius
B: mouse (aka mus musculus)
C: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
D: mus cricetus (aka cricetus cricetus)
E: fruit fly (aka drosophila <flies,genus>)
F: bos bovis (aka bos taurus)
G: mus <subgenus> (mus (aka mus <subgenus>))
H: equidae (horses) (aka equidae)
I: flies (aka diptera)
J: mice (aka mus sp.) (aka mus sp.)
K: mus <genus> (mice (aka mus <genus>))
L: rattus (rats (aka rattus))
M: mus norvegicus (aka rattus norvegicus)
N: hawaiian drosophila
O: rats (aka rattus sp.) (aka rattus sp.)
P: melanogaster subgroup
Q: melanogaster (aka melanogaster <flies>)
R: bovidae
S: gallus
T: rattus norvegicus albus
U: None of the above. | [M; B; E; F] |
<Instruct>: Given the context 'INTRODUCTION
In mammals DNA polymerase a is thought to be the replicative
enzyme, but due to low levels of activity, even in tissues actively making DNA, and to enzyme heterogeneity it has been found difficult to purify
However, small samples of DNA polymerase a have been highly purified
2, 3, 4, 5 from several sources and partially characterised
Heterogeneity has been observed in DNA polymerase a from a var
6 7
iety of sources, including rat liver and spleen , Hela cells, baby hamster
8 9, 10 11
kidney cells , mouse myeloma , Drosophila embryos and calf thymus
1,6, 12, 13 .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse; drosophila; calf]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: equidae (horses) (aka equidae)
C: rattus norvegicus albus
D: fruit fly (aka drosophila <flies,genus>)
E: house rat (aka rattus rattus)
F: melanogaster subgroup
G: melanogaster <flies> (melanogaster) (aka melanogaster <flies>)
H: equine (aka equus caballus)
I: drosophila <flies,subgenus> (drosophila) (aka drosophila <flies,subgenus>)
J: melanogaster group
K: bovidae
L: house mouse (aka mus musculus)
M: bos bovis (aka bos taurus)
N: mus sp. (mice (aka mus sp.))
O: cattle (aka bos)
P: rattus rattoides (aka rattus pyctoris)
Q: rat (aka rattus) (aka rattus)
R: mus molossinus (aka mus musculus molossinus)
S: mus <subgenus> (mus (aka mus <subgenus>))
T: brown rat (aka rattus norvegicus)
U: None of the above. | [T; L; D; M] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.